Critical Care Pharmacy Review Course, Pract Exam, and Core Therapeutic Modules Package (Cert # L199186)

ACPE Numbers: Various – see listing below
Pre-Sale Date: 09/04/2019
Content Release Date: 09/25/2019
Expiration Date: 08/31/2020
Activity Type: Application-based
CE Credits: 26 hours (ACPE only)
Activity Fee: $425 (ASHP member); $625 (non-member) 

ASHP has opened access to this package making it available to all pharmacists at no cost through May 31.  Please use discount code: COVID-19 at checkout. ASHP is committed to supporting all healthcare providers from around the world during the COVID-19 pandemic.

Accreditation for Pharmacists

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  


Target Audience

These activities are intended for pharmacists who are seeking to update their knowledge and skills commensurate with a board certification examination in the areas listed below. 

Activity Overview

This online course provides a robust preparatory curriculum for the pharmacy professional preparing for the Board of Pharmacy Specialties (BPS) Critical Care Pharmacy Specialty Certification Examination. Designed based on the domains, tasks, and knowledge statements developed by the BPS for the certification examination, this course will help you prepare for the exam by identifying areas needed for in‐depth review of critical care pharmacy issues by:

  • Reviewing pertinent clinical topics and practice skills
  • Providing exam practice questions
  • Listing valuable references for further study

This course is NOT intended for those obtaining recertification credit. To earn recertification credit, please see courses here: 

These activities are part of the ASHP professional development program. 

Review Course Modules

This course consists of 11 activities (see table below) and provides up to 16 hours of continuing pharmacy education credit. The Review Course includes case-based presentations for application to real-life scenarios, a practice exam along with correct answers, and links to the reference sources, and domains, tasks, and knowledge statements. To help you further prepare, this package includes a compilation of practice questions in the same format and rigor to help you prepare for the BPS Specialty Examination.       

Learning Module

ACPE Number

Credit Hours

ACPE Expiration Date

Complex Case: Complications after Cardiac Surgery - Glucose, Sedation, and Thrombocytopenia

0204-0000-19-973-H01-P

1.50

09/25/2022

Complex Case: Acute Coronary Syndrome

0204-0000-19-974-H01-P

1.50

Complex Case: Antithrombotic-associated Intracranial Hemorrhage

0204-0000-19-975-H01-P

1.50

Complex Case: Sepsis

0204-0000-19-976-H01-P

1.50

Complex Case: Hyperglycemic Emergency and Community-Acquired Pneumonia

0204-0000-19-978-H01-P

1.50

Complex Case: Pneumonia

0204-0000-19-979-H01-P

1.50

Complex Case: Oncologic Emergencies: Febrile Neutropenia and Tumor Lysis Syndrome

0204-0000-19-980-H01-P

1.50

Complex Case: GI Bleeding and Acute Renal Failure

0204-0000-19-981-H01-P

1.50

Statistics, Evidence-Based Medicine, and Clinical Trial Design

0204-0000-18-934-H04-P

2.00

Practice Administration and Development Part 1

0204-0000-19-983-H04-P

1.00

Practice Administration and Development Part 2

0204-0000-19-984-H04-P

1.00

                                             

Review Course Learning Objectives                                               

After participating in this CPE activity, learners should be able to: 

ACPE Number:0204-0000-19-973-H01-P
  • Develop appropriate treatment and monitoring plans for a complex post-cardiac surgery patient to include pain, agitation and delirium, glucose management, and heparin-induced thrombocytopenia.
  • Examine the impact of critical illness on pre-existing conditions (e.g., endocrine disorders, pain).
  • Summarize quality assurance and process improvement methods relevant to critical care.
  • Assess the relationship between institutional guideline development and evidence-based critical care literature. 
ACPE Number: 0204-0000-19-974-H01-P
  • Develop appropriate treatment and monitoring plans for a complex critical care patient with acute coronary syndrome.
  • Modify treatment and monitoring plans related to alterations of pharmacodynamics and pharmacokinetics in the critically ill.
  • Select appropriate devices required for treatment and monitoring of a critical care patient.
  • Identify appropriate fluid, electrolyte and acid/base management and monitoring based on patient-specific factors. 
ACPE Number: 0204-0000-19-975-H01-P
  • Develop appropriate plans for treatment and monitoring of a complex critical care patient with antithrombotic-associated intracerebral hemorrhage (ICH).
  • Select appropriate neurologic monitoring techniques.
  • Recommend appropriate use of agents for acute volume resuscitation and hemostasis (e.g., blood products, hemostatic agents).
  • Examine the impact of critical illness on preexisting conditions (e.g., cardiovascular diseases).
  • Explain the appropriate management of hyponatremia based on patient-specific factors. 
ACPE Number: 0204-0000-19-976-H01-P
  • Develop appropriate treatment and monitoring plans for a complex critical care patient with an intra-abdominal infection, sepsis/SIRS, and shock.
  • Select appropriate routes of administration for medications in critically ill patients.
  • Modify treatment and monitoring plans related to alterations of pharmacodynamics and pharmacokinetics in the critically ill.
  • Identify appropriate use of agents for acute volume resuscitation and hemostasis (e.g., crystalloids, colloids). 
Complex Case: Hyperglycemic Emergency and Community-Acquired Pneumonia
ACPE Number: 0204-0000-19-978-H01-P
  • Develop appropriate treatment and monitoring plans for a complex critical care patient with hyperglycemic emergency and community-acquired pneumonia.
  • Select appropriate routes and methods of administration for medications in critically ill patients.
  • Select appropriate fluid, electrolyte and acid/base management and monitoring based on patient-specific factors.
  • Choose appropriate use of agents for acute volume resuscitation.
  • Identify medication safety issues and strategies pertinent to patients requiring care in the ICU.
  • Identify appropriate nutrition support in the critically ill patient.  
Complex Case: Pneumonia
ACPE Number: 0204-0000-19-979-H01-P
  • Develop appropriate treatment and monitoring plans for a complex critical care patient with multiple conditions, including pneumonia and acute respiratory distress syndrome (ARDS).
  • Identify drug interactions and adverse drug events common in critical care and methods to document. 

Complex Case: Oncologic Emergencies: Febrile Neutropenia and Tumor Lysis Syndrome
ACPE Number: 0204-0000-19-980-H01-P

  • Develop appropriate treatment and monitoring plans for a complex critical care patient with febrile neutropenia, tumor lysis syndrome, or hypercalcemia.
  • Identify appropriate fluid, electrolyte and acid/base management and monitoring based on patient-specific factors.
  • Examine the impact of critical illness on pre-existing conditions (e.g., cancer). 
Complex Case:  GI Bleeding and Acute Renal Failure
ACPE Number: 0204-0000-19-981-H01-P
  • Develop appropriate treatment and monitoring plans for a complex critical care patient with gastrointestinal bleeding, alcohol withdrawal, refeeding syndrome, hepatorenal syndrome, cirrhosis, and acute renal failure with renal replacement therapy.
  • Modify treatment and monitoring plans related to alterations of pharmacodynamics and pharmacokinetics in the critically ill.
  • Select appropriate routes of administration for medications in critically ill patients.
  • Identify appropriate use of agents for acute volume resuscitation and hemostasis (e.g., blood products, hemostatic agents). 
Statistics, Evidence-Based Medicine, and Clinical Trial Design
ACPE Number: 0204-0000-18-934-H04-P
  • Determine quality and appropriateness of a study by examining study design, statistical analysis, sources of bias, quality of conclusions, and interpretation of graphs.
  • Determine clinical and statistical significance of a study outcome.
  • Determine whether the study applies to a specified patient population. 
Practice Administration and Development Part 1
ACPE Number: 0204-0000-19-983-H04-P
  • Develop a plan to monitor and evaluate compliance with, and impact of, policies and guidelines (e.g., institutional, evidence based).
  • Describe the application and integration of evidence-based critical care literature into institutional guidelines and processes.
  • Evaluate regulatory/IRB requirements relative to conducting critical care research.
  • Select quality assurance methods and improvement activities, including needs assessment techniques, aimed at enhancing the safety and effectiveness of medication-use processes in the critical care area. 
Practice Administration and Development Part 2
ACPE Number: 0204-0000-19-984-H04-P
  • Identify metrics for evaluating the quality of critical care pharmacy services (e.g., lengths of ICU stay, mortality, cost-effectiveness, ROI).
  • Examine the evidence-based literature that supports the value of critical care pharmacy.
  • Summarize the factors that enhance the education and training of critical care pharmacists available in published documents from relevant professional societies (e.g., ASHP, ACCP, SCCM). 

Core Therapeutic Modules

The Core Therapeutic Modules Review Package consists of 10 activities in which faculty review clinical topics and practice skills using a case-based approach. The activities are designed to assist the learner in identifying knowledge gaps in preparation for a pharmacy specialty board examination. In addition to a recorded presentation, each activity includes links to resources for further self-study and a practice test developed in the same format and rigor as the specialty exam.

 

Learning Module

ACPE Number

Credit Hours

ACPE Expiration Date

Select Topics in Acid-Base Disorders

0204-0000-18-981-H01-P

1

09/12/21

Select Topics in Infectious Diseases in Critical Care Patients

0204-0000-19-600-H01-P

1

09/25/22

Select Neurology Topics in Critical Care Patients

0204-0000-17-938-H01-P

1

05/30/20

Alterations in Pharmacokinetics and Pharmacodynamics in Critical Care

0204-0000-18-987-H01-P

1

09/12/21

Select Topics in Prevention and Supportive Care in Critical Care Patients

0204-0000-17-939-H01-P

1

05/30/20

Select Topics in Toxicology

0204-0000-18-994-H01-P

1

09/12/21

Select Topics in Pulmonary Disorders

0204-0000-19-601-H01-P

1

09/25/22

Cardiac Arrhythmias and Advanced Cardiac Life Support

0204-0000-19-603-H01-P

1

07/16/22

Pharmacotherapy Considerations in the Management of Shock

0204-0000-17-931-H01-P

1

05/30/20

Fluid, Electrolytes, and Nutrition

0204-0000-19-602-H01-P

1

09/25/22

 

Core Therapeutic Learning Objectives

Select Topics in Acid-Base Disorders
ACPE Number: 0204-0000-18-981-H01-P
  • For the following specific acid-base disorders - respiratory, metabolic acid-base disorders including anion gap/non-anion gap acidosis, renal tubular acidosis, as well as the delta gap equation:
    • Interpret diagnostic and laboratory tests.
    • Determine the most appropriate treatment and monitoring based on patient-specific information and the most current guidelines.
    • Assess available information to identify drug-related problems and response to therapy.
    • Identify appropriate modifications of patient-specific treatment plans based on follow-up assessment. 
Select Topics in Infectious Diseases in Critical Care Patients
ACPE Number: 0204-0000-19-600-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • For the following specific infectious disease topics: urinary tract infections, meningitis, tuberculosis and catheter related infections:
    • Interpret laboratory and diagnostic tests.
    • Formulate the most appropriate treatment and monitoring plans based on patient-specific information and current guidelines.
    • Interpret available information to manage drug-related problems, evaluate response to therapy, and modify patient-specific treatment plans based on follow-up assessment. 
Select Neurology Topics in Critical Care Patients
ACPE Number: 0204-0000-17-938-H01-P

For the following specific critical care topics: status epilepticus, traumatic brain injury, ischemic stroke and subarachnoid hemorrhage:

  • Interpret diagnostic and/or laboratory tests in patients
  • Assess benefit and risks of drug therapy considering other medication, and other patient-specific factors
  • Determine the most appropriate treatment and monitoring based on patient-specific information and the most current guidelines
  • Assess available information to identify drug-related problems and response to therapy
  • Identify appropriate modifications of patient-specific treatment plans based on follow-up assessment 
Alterations in Pharmacokinetics and Pharmacodynamics in Critical Care
ACPE Number: 0204-0000-18-987-H01-P
  • Review general pharmacokinetic (PK) and pharmacodynamic (PD) principles
  • For the following PK/PD challenges – burns, obesity, pregnancy, device-related, extracorporeal membrane oxygenation (ECMO):
    • Interpret diagnostic and laboratory tests.
    • Determine most appropriate treatment and monitoring based on patient-specific data.
    • Assess available information to identify drug-related problems and therapy response.
    • Identify appropriate modifications of patient-specific treatment plans based on follow-up assessment. 
Select Topics in Prevention and Supportive Care in Critical Care Patients
ACPE Number: 0204-0000-17-939-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Assess benefits and risk of drug therapy considering patient-specific factors.
  • Determine the most appropriate treatment based patient-specific information and the most current guidelines.
  • Assess available information to identify drug-related problems and response to therapy.
  • Identify appropriate modifications of patient-specific treatment plans based on follow-up assessment. 
Select Topics in Toxicology
ACPE Number: 0204-0000-18-994-H01-P
  • For the following specific toxicology topics: acetaminophen, toxic alcohols, calcium channel blockers, beta blockers, opioids, and ecstasy:
    • Interpret diagnostic and/or laboratory tests.
    • Determine the most appropriate treatment and monitoring based on patient-specific information and the most current guidelines.
    • Assess available information to identify drug-related problems and response to therapy.
    • Identify appropriate modifications of patient-specific treatment plans based on follow-up assessment. 
Select Topics in Pulmonary Disorders
ACPE Number: 0204-0000-19-601-H01-P
  • For the following specific pulmonary topics: asthma exacerbation, acute exacerbation of chronic obstructive pulmonary disease (COPD), and pulmonary embolism:
    • Interpret laboratory and diagnostic tests.
    • Formulate the most appropriate treatment and monitoring plans based on patient-specific information and current guidelines.
    • Interpret available information to manage drug-related problems, evaluate response to therapy, and modify patient-specific treatment plans based on follow-up assessment. 
Cardiac Arrhythmias and Advanced Cardiac Life Support
ACPE Number: 0204-0000-19-603-H01-P

At the conclusion of this application-based educational activity, participants should be able to

  • Interpret signs, symptoms and diagnostic tests for cardiac arrhythmias.
  • Identify drug-related problems, including drug interactions and adverse effects, associated with pharmacotherapy of cardiac arrhythmias.
  • Identify and prevent drug-induced cardiac arrhythmias.
  • Determine the most appropriate therapy and monitoring for cardiac arrhythmias based on patient-specific information and the most current guidelines.
  • Utilize advanced cardiac life support (ACLS) guided therapies. 
Pharmacotherapy Considerations in the Management of Shock
ACPE Number: 0204-0000-17-931-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Interpret diagnostic and/or laboratory tests, vital signs, and clinical presentation in order to differentiate types of shock (hypovolemic, distributive, cardiogenic).
  • Compare and contrast the pharmacologic agents utilized in shock.
  • Determine the most appropriate therapy and monitoring based on patient-specific information and the most current guidelines for the treatment of shock. 
Fluid, Electrolytes, and Nutrition
ACPE Number: 0204-0000-19-602-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Interpret laboratory and diagnostic tests to evaluate fluid, electrolyte and nutrition status.
  • Select the appropriate route for nutrition administration, and evaluate if nutrition needs are being met based on patient-specific information and current guidelines.
  • Manage drug-related electrolyte interactions and nutrient interactions.
  • Determine the most appropriate therapy and monitoring in patients with fluid, electrolyte, and nutritional disorders based on patient-specific information and current guidelines. 

Faculty

View full faculty bios here

Angela L. Bingham, Pharm.D., BCPS, BCNSP, BCCCP*
Associate Professor of Clinical Pharmacy
University of the Sciences-Philadelphia College of Pharmacy
Philadelphia, Pennsylvania
Critical Care/Nutrition Support Clinical Pharmacy Specialist
Cooper University Health Care
Camden, New Jersey
Quinn Czosnowski, Pharm.D., BCCCP
Clinical Pharmacist - Critical Care
Methodist and University Hospitals
Indianapolis, Indiana
Brian Dee, Pharm.D., BCCCP, BCNSP
Clinical Pharmacy Specialist – Critical Care/Nutrition Support
The University of Texas MD Anderson Cancer Center
Houston, Texas
Chris Droege, Pharm.D., BCCCP, FCCM, FASHP
Clinical Pharmacy Specialist, Critical Care
UC Health - University of Cincinnati Medical Center
Cincinnati, Ohio
Karrie Derenski, Pharm.D., BCNSP, BCCCP, CNSC
Pharmacy & Metabolic Support Supervisor
Cox Health
Springfield, Missouri 
Mary Hess, Pharm.D., B.S.Pharm., BCCCP, FASHP, FCCM, FCCP*
Associate Dean of Student Affairs
Jefferson College of Pharmacy
Philadelphia, Pennsylvania 
Lauren Igneri, Pharm.D., BCPS, BCCCP
Clinical Pharmacy Specialist
Cooper University Health Care
Camden, New Jersey
Morgan G. Jones, Pharm.D., BCCCP, BCPS, FCCM
Clinical Pharmacy Specialist - Neurocritical Care
Methodist University Hospital
Memphis, Tennessee
Patricia Kienle, RPh, MPA, FASHP
Director, Accreditation and Medication Safety
Cardinal Health Innovative Delivery Solutions
Wilkes-Barre, Pennsylvania 
Daniel R. Malcom, Pharm.D., BCPS
Assistant Professor, Department of Clinical and Administrative Sciences
Sullivan University College of Pharmacy
Louisville, Kentucky
Director, Clinical Pharmacy Services
Massachusetts General Hospital
Boston, Massachusetts
Jill Starykowicz, Pharm.D., BCCCP
Clinical Pharmacy Specialist, Medical and Cardiac Intensive Care Unit
Advocate Lutheran General Hospital
Park Ridge, Illinois
Paul M. Szumita, Pharm.D., BCCCP, BCPS, FASHP, FCCM*
Clinical Pharmacy Practice Manager
Brigham and Women’s Hospital
Boston, Massachusetts
Rachel Swope, Pharm.D., BCCCP, BCPS
Critical Care Pharmacy Specialist
Norton Healthcare
Louisville, Kentucky 
Heather Torbic, PharmD, BCPS, BCCCP
Medical ICU Clinical Specialist
Cleveland Clinic
Cleveland, Ohio

*Content matter experts

Reviewers

Anna M. Jackson, Pharm.D., BCPS
Holly Byrnes, Pharm.D., BCPS
Susan R. Dombrowski, M.S., R.Ph. 

Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content. 

All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity. 

All planners, presenters, and reviewers of this session report no financial relationships relevant to this activity. 

Methods and CE Requirements

Activities can be completed in any order. Each activity consists of audio, video, and/or PDFs and evaluations. Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity. 

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity. 

System Technical Requirements

Learning activities are delivered via your Web browser and Acrobat PDF. For all activities you should have a basic comfort level using a computer and navigating web sites. 

View the minimum technical and system requirements for learning activities. 

Development

These activities were developed by ASHP.

To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for Board Certification Examinations.